Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Protocols in Neuroscience|October 24, 2017
Bioluminescence Resonance Energy Transfer Assay to Characterize Gi-Like G Protein Subtype-Dependent Functional SelectivityHideaki Yano, Marta Sánchez-Soto, Sergi Ferré
Communications Chemistry|May 20, 2026
Phenotypic AI-based design of cell-specific small molecule cytotoxicsGema Rojas-Granado, Marta Sánchez-Soto, Jesús Calahorra, et al.
Molecular Neurobiology|November 3, 2018
Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor VariantMarta Sánchez-Soto, Hideaki Yano, Ning-Sheng Cai, et al.
Molecular Pharmacology|February 5, 2016
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor AgonistMarta Sánchez-Soto, Alessandro Bonifazi, Ning Sheng Cai, et al.
Pharmacological Research|June 28, 2021
Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disordersVerònica Casadó-Anguera, Estefanía Moreno, Marta Sánchez-Soto, et al.
Molecular Neurobiology|March 20, 2018
α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor LigandsMarta Sánchez-Soto, Verònica Casadó-Anguera, Hideaki Yano, et al.
Molecular Neurobiology|March 29, 2019
Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus AccumbensXavier Guitart, Estefanía Moreno, William Rea, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Molecular Pharmacology|August 7, 2014
Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramerXavier Guitart, Gemma Navarro, Estefania Moreno, et al.
Genome Medicine|October 27, 2021
Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse modelsEduardo Pauls, Sergi Bayod, Lídia Mateo, et al.
Pageof 2